Subscribe today!
Research Areas
Research Areas
Neuroscience
Cancer Research
Immunology
Infectious Disease & Vaccines
Hematology
Ophthalmology
Rare & Genetic Diseases
Dermatology
Internal Medicine
Metabolic Disease
Tools & Techniques
All Research Areas
News
Magazine
Multimedia
Multimedia
Webinars
eBooks
Podcasts
Infographics
Videos
Milestones - Articles
Explainers - Articles
Industry Perspectives
Compendiums
Whitepapers
Application Notes
All Multimedia
Research Areas
Research Areas
Neuroscience
Cancer Research
Immunology
Infectious Disease & Vaccines
Hematology
Ophthalmology
Rare & Genetic Diseases
Dermatology
Internal Medicine
Metabolic Disease
Tools & Techniques
All Research Areas
News
Magazine
Multimedia
Multimedia
Webinars
eBooks
Podcasts
Infographics
Videos
Milestones - Articles
Explainers - Articles
Industry Perspectives
Compendiums
Whitepapers
Application Notes
All Multimedia
Subscribe!
Subscribe Today!
Jim Cirigliano
This person does not yet have a bio.
Articles by Jim Cirigliano
| 4 min read
by
Jim Cirigliano
Data recommend RECCE 327
Synthetic antibiotic shows efficacy against priority antibiotic-resistant pathogen
Articles
| 3 min read
by
Jim Cirigliano
Positive pain relief
New compound may help reduce chronic opioid use and facilitate dose tapering
Articles
| 3 min read
by
Jim Cirigliano
Building compounds less expensively
Rice team publishes simple aziridination method for synthesizing pharmaceutical building blocks
Articles
| 3 min read
by
Jim Cirigliano
A ‘liquid’ asset
Liquid biopsy aims to accelerate biomarker-driven precision cancer therapies
Articles
| 3 min read
by
Jim Cirigliano
Knowing the score
New application helps authors, publishers address heightened reproducibility and transparency standards
Articles
| 4 min read
by
Jim Cirigliano
A new idea with IDO
Phase 2 trial evaluates a new tool in pediatric cancer immunotherapy
Articles
| 2 min read
by
Jim Cirigliano
Gut check
French biotech company raises €6.2M for gut microbiome R&D
Articles
| 3 min read
by
Jim Cirigliano
A break in the case
Two enzymes indicted in inflammation and tumor growth in non-small cell lung carcinomas
Articles
| 3 min read
by
Jim Cirigliano
Immunotherapies vs. infections
Breakthrough research identifies a potential vaccine against deadly fungus
Articles
| 3 min read
by
Jim Cirigliano
Keep a good thing going
Expanded collaboration in Huntington’s disease research to explore stem cell and genetic therapeutics
Articles
| 3 min read
by
Jim Cirigliano
Copper conflict
Staphyloccocus genes offer potential pathways for overcoming antibacterial resistance
Articles
| 4 min read
by
Jim Cirigliano
Paving the way
Shingles treatment the first of several herpesvirus drug candidates to enter IND-enabling studies
Articles
Page 1 of 8 - 95 Total Items
1
2
3
4
5
6
7
8
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
Subscribe
Sponsored
Rethinking separation science with supercritical fluids
Discover how supercritical fluids expand chromatographic capabilities across diverse analytical challenges.
Infographics
Advancing bioconjugate development through innovative approaches
Evolving approaches to conjugation chemistry and linker–payload design are helping address persistent challenges in bioconjugate development.
Whitepaper
Advancing predictive
in vitro
models
Explore how emerging
in vitro
systems — built from primary cells, cocultures, and vascularized tissues — are improving translational research outcomes.
Webinars
Latest Issue
Volume 21 • Issue 4 • December 2025
December 2025
December 2025 Issue
Explore this issue